Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era
暂无分享,去创建一个
Kazuhiko Yoshida | K. Tanabe | Y. Hashimoto | Hirohito Kobayashi | J. Iizuka | T. Takagi | T. Kondo | H. Fukuda | H. Shimmura | Hiroki Ishihara | Kazutaka Nakamura | Yukiaki Nemoto | H. Tachibana